First-in-Human Phase I Trial of TPST-1120, an inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors
Article in Cancer Research Communications (April 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Article in Cancer Research Communications (April 2024)
Article in Food Science and Human Wellness (January 2024)
Article in Annals of Hepatology (March 2023)